Hacd2tm1d(EUCOMM)Hmgu
Targeted Allele Detail
|
Symbol: |
Hacd2tm1d(EUCOMM)Hmgu |
Name: |
3-hydroxyacyl-CoA dehydratase 2; targeted mutation 1d, Helmholtz Zentrum Muenchen GmbH |
MGI ID: |
MGI:7444806 |
Synonyms: |
Hacd2completeKO |
Gene: |
Hacd2 Location: Chr16:34842798-34929547 bp, + strand Genetic Position: Chr16, 24.54 cM
|
Alliance: |
Hacd2tm1d(EUCOMM)Hmgu page
|
IMPC: |
Hacd2 gene page |
|
Mutant Cell Lines: |
HEPD0663_6_A10, HEPD0663_6_G09 |
Germline Transmission: |
Earliest citation of germline transmission:
J:333944
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
EUCOMM
|
|
Allele Type: |
|
Targeted (Null/knockout) |
Mutation: |
|
Intragenic deletion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 34845737 of Chromosome 16 upstream of the critical exon 2 (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of exon 2 at position 34846568. Exon 2 is thus flanked by loxP sites. A null/knockout allele was created by flp and cre recombinase expression in mice carrying this allele to remove the lacZ sequence, neo selection cassette and the loxP-flanked exon 2. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:333944)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Hacd2 Mutation: |
18 strains or lines available
|
|
Original: |
J:333944 Khadhraoui N, et al., Hacd2 deficiency in mice leads to an early and lethal mitochondrial disease. Mol Metab. 2023 Mar;69:101677 |
All: |
1 reference(s) |
|